English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [912]
News [3692]
Articles [22]
Editorials [1]
Conferences [136]
elearning [0]
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure
EHA 2022: Dysregulation of RNA binding proteins drive hematopoietic stem cell exhaustion and bone marrow failure
EHA 2022: A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory multiple myeloma
EHA 2022: A novel CAR-T cell therapy targeting BCMA is highly effective for patients with relapsed/refractory...
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple myeloma patients
ASCO 2022: Autologous stem cell transplant showed improved progression-free survival in newly diagnosed multiple...
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer
ASCO 2022: Combination regimen improves overall survival in a type of newly diagnosed metastatic colorectal cancer
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
ASCO 2022: Drug combination shows promise against cancer’s ‘death star’ protein
ASCO 2022: Liquid biopsy can help identify the need for adjuvant therapy in stage II colon cancer
ASCO 2022: Liquid biopsy can help identify the need for adjuvant therapy in stage II colon cancer
ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell lymphoma
ASCO 2022: Ibrutinib improves progression-free survival by 50% for older patients with newly diagnosed mantle cell...
'Masked' cancer drug sneaks through body to deliver anti-tumour treatment with fewer side effects
'Masked' cancer drug sneaks through body to deliver anti-tumour treatment with fewer side effects
The paired perils of breast cancer and diabetes
The paired perils of breast cancer and diabetes
<1...5354555657...370>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top